###begin article-title 0
c-Src Regulates Akt Signaling in Response to Ghrelin via beta-Arrestin Signaling-Independent and -Dependent Mechanisms
###end article-title 0
###begin p 1
Conceived and designed the experiments: JPC. Performed the experiments: ML. Analyzed the data: ML MT FFC JPC. Contributed reagents/materials/analysis tools: MT MP. Wrote the paper: JPC.
###end p 1
###begin p 2
###xml 315 318 315 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i/o</sub>
###xml 419 422 416 419 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i/o</sub>
###xml 142 147 <span type="species:ncbi:9606">human</span>
The aim of the present study was to identify the signaling mechanisms to ghrelin-stimulated activation of the serine/threonine kinase Akt. In human embryonic kidney 293 (HEK293) cells transfected with GHS-R1a, ghrelin leads to the activation of Akt through the interplay of distinct signaling mechanisms: an early Gi/o protein-dependent pathway and a late pathway mediated by beta-arrestins. The starting point is the Gi/o-protein dependent PI3K activation that leads to the membrane recruitment of Akt, which is phosphorylated at Y by c-Src with the subsequent phosphorylation at A-loop (T308) and HM (S473) by PDK1 and mTORC2, respectively. Once the receptor is activated, a second signaling pathway is mediated by beta-arrestins 1 and 2, involving the recruitment of at least beta-arrestins, c-Src and Akt. This beta-arrestin-scaffolded complex leads to full activation of Akt through PDK1 and mTORC2, which are not associated to the complex. In agreement with these results, assays performed in 3T3-L1 preadipocyte cells indicate that beta-arrestins and c-Src are implicated in the activation of Akt in response to ghrelin through the GHS-R1a. In summary this work reveals that c-Src is crucially involved in the ghrelin-mediated Akt activation. Furthermore, the results support the view that beta-arrestins act as both scaffolding proteins and signal transducers on Akt activation.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 57 58 57 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 201 204 201 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-vanderLely1">[1]</xref>
###xml 479 482 476 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Camia1">[2]</xref>
###xml 484 487 481 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Holliday1">[3]</xref>
###xml 755 758 752 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Camia1">[2]</xref>
###xml 973 976 967 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Luttrell1">[4]</xref>
###xml 1067 1070 1058 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Holliday1">[3]</xref>
###xml 1500 1503 1485 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-DeWire1">[5]</xref>
The growth hormone secretagogue receptor type 1a (GHS-R1a1) transduces the main signals carried by ghrelin participating in the regulation of growth hormone release, food intake and energy homeostasis [1]. Ghrelin stimulation of GHS-R1a results in activation of heterotrimeric G proteins followed by receptor phosphorylation that leads to the beta-arrestin recruitment, which then sterically interdicts further coupling to G proteins and targets the receptor for internalization [2], [3]. The ghrelin/GHS-R1a complex is internalized by a clathrin-mediated mechanism through an endosomal trafficking pathway. Once the ligand-receptor complex is internalized into vesicles, GHS-R1a is sorted into endosomes to be slowly recycled back to the plasma membrane [2]. This slow recycling might be determined by the stability of the complex GHS-R1a/beta-arrestin during clathrin-mediated endocytosis since this complex appears to dictate the profile of the receptor resensitization [4]. Indeed, ghrelin-stimulated GHS-R1a shows significant endosomal beta-arrestin recruitment [3]. In addition to the role of beta-arrestin in terminating G protein signaling, recent studies have demonstrated that beta-arrestins also function as scaffold molecules for numerous signaling networks such as protein kinases, including the mitogen activated protein kinases, extracellular signal-regulated kinase (ERK), c-Jun NH2-terminal Kinase (JNK), and p38 mitogen-activated protein kinase (p38), as well as Akt, PI3K and RhoA [5].
###end p 4
###begin p 5
###xml 223 226 220 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Camia2">[6]</xref>
###xml 244 247 241 244 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i/o</sub>
###xml 426 430 411 415 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q/11</sub>
###xml 1170 1173 1129 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-DeWire1">[5]</xref>
The signaling mechanisms that underlie the activation of the mitogenic ERK growth response by the GHS-R1a are complex and result from both classical G protein-regulated effectors and beta-arrestin dependent ERK recruitment [6]. One pathway is Gi/o-dependent and it is mediated by phosphatidylinositol 3-kinase (PI3K), protein kinase Cepsilon (PKCepsilon) and non-receptor tyrosine kinase c-Src (c-Src). The second pathway is Gq/11-dependent and involves the activation of protein kinase Calpha/beta (PKCalpha/beta) and c-Src. A third pathway involves the recruitment of GHS-R1a, c-Src, Raf-1 and ERK 1/2 into a beta-arrestin-scaffolded complex. G protein and beta-arrestin mediated ERK pathways are both temporally different and act in a sequential way. The beta-arrestin-scaffolded signaling complex persists for prolonged periods and it is probably determined by the stability of the beta-arrestin /ghrelin receptor complexes. It has become increasingly recognized that these scaffolding complexes can determine the subcellular location and specificity, promoting phosphorylation of diverse cytosolic substrates and thereby having different physiological consequences [5].
###end p 5
###begin p 6
###xml 176 179 176 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Manning1">[7]</xref>
###xml 255 258 255 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Xu1">[8]</xref>
###xml 259 263 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Zhao1">[11]</xref>
###xml 281 285 281 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Barazzoni1">[12]</xref>
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Park1">[13]</xref>
###xml 315 319 315 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Kim1">[14]</xref>
###xml 341 345 341 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Duxbury1">[15]</xref>
The GHS-R1a has been implicated in Akt signaling, a serine/threonine kinase that exerts a central role in the regulation of metabolism, apoptosis, transcription and cell-cycle [7]. Although previous studies have shown the activation of Akt in endothelial [8]-[11], skeletal muscle [12], thyroid [13], preadipocytes [14] and pancreatic cells [15], the molecular events that follow GHS-R1a ligand binding to trigger Akt activation remain unknown. To better understand these molecular mechanisms, we used HEK 293 cells stably expressing the GHS-R1a (HEK-GHSR1a) and 3T3-L1 preadipocyte cells. The experiments were designed to assess the roles, if any, played by G proteins and beta-arrestins.
###end p 6
###begin title 7
Methods
###end title 7
###begin title 8
Materials
###end title 8
###begin p 9
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 205 211 <span type="species:ncbi:9986">rabbit</span>
###xml 241 247 <span type="species:ncbi:9986">rabbit</span>
###xml 315 321 <span type="species:ncbi:9986">rabbit</span>
###xml 346 352 <span type="species:ncbi:9986">rabbit</span>
###xml 375 381 <span type="species:ncbi:9986">rabbit</span>
###xml 415 421 <span type="species:ncbi:9986">rabbit</span>
###xml 605 611 <span type="species:ncbi:9986">rabbit</span>
###xml 705 709 <span type="species:ncbi:9925">goat</span>
###xml 743 748 <span type="species:ncbi:10090">mouse</span>
###xml 775 781 <span type="species:ncbi:9986">rabbit</span>
###xml 1010 1016 <span type="species:ncbi:9986">rabbit</span>
###xml 1017 1028 <span type="species:ncbi:3704">horseradish</span>
###xml 1096 1100 <span type="species:ncbi:9925">goat</span>
###xml 1101 1112 <span type="species:ncbi:3704">horseradish</span>
###xml 1167 1173 <span type="species:ncbi:9986">Rabbit</span>
###xml 1179 1182 <span type="species:ncbi:10116">rat</span>
Human ghrelin was obtained from Global Peptide (CO, USA). Pertussis toxin was from Sigma (St. Louis, Mo, USA). Wortmannin, PP2 and PP3 were purchased from Calbiochem (San Diego, CA, USA). Anti-p44/42 MAPK rabbit polyclonal, anti-pSrc (Y416) rabbit polyclonal, anti-pAkt HM (S473), anti-pAkt A-loop (T308), anti-Akt rabbit polyclonal, anti-Rictor rabbit polyclonal, anti-mTOR rabbit polyclonal and anti-pPDK1 (S241) rabbit polyclonal antibodies were from Cell Signaling Technology (Beverly, MA, USA). Rictor siRNA and siRNA control were synthesized by Cell Signaling Technology (Beverly, MA, USA). Anti-pY rabbit polyclonal antibody was from Upstate Technology (Lake Placed, NY, USA). Anti-beta-arrestin 1 goat polyclonal, anti-beta-arrestin 2 mouse monoclonal and anti-c-Src rabbit polyclonal antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). beta-arrestin 1 siRNA, beta-arrestin 2 siRNA, c-Src siRNA and siRNA control were likewise from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-rabbit horseradish peroxidase was from GE-Amersham, (Buckinghamshire, UK), while anti-goat horseradish peroxidase was from Santa Cruz (Santa Cruz, CA, USA). Rabbit anti-rat beta-arrestin 1C-terminal (A1CT) antiserum was provided by Prof. R.J. Lefkowitz (Duke University Medical Center, Durham, NC, USA).
###end p 9
###begin title 10
Cell culture
###end title 10
###begin p 11
###xml 118 121 118 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Camia1">[2]</xref>
###xml 367 368 367 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 239 243 <span type="species:ncbi:9913">calf</span>
HEK 293 cells, which stably express the human ghrelin receptor 1a (HEK-GHSR1a), were cultured as previously described [2]. 3T3-L1 preadipocyte cells were obtained from American Type Culture Collection and maintained in DMEM containing 10% calf serum, 100 U/ml penicillin, and 100 U/ml streptomycin. Cells were grown under a humidified atmosphere of 95% air, and 5% CO2 at 37degreesC.
###end p 11
###begin title 12
Cell transient transfection
###end title 12
###begin p 13
###xml 476 480 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Theodoropoulou1">[16]</xref>
The cDNA encoding Gbetagamma sequester beta-ARK-CT (gift of P. Voigt, Institute of Pharmacology, Charite-Medical Universiy, Campus Benjamin Franklin, Berlin, Germany) was transfected into subconfluent HEK-GHSR1a cells using Lipofectamine 2000 (Invitrogen; Carlsbad, CA, USA) following the manufacture's protocol. The beta-ARK-CT incorporation was confirmed by means of intracellular calcium measurements in transfected cells before and after treatment as previously described [16].
###end p 13
###begin title 14
Immunoblotting analysis
###end title 14
###begin p 15
###xml 530 531 518 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
Serum-starved cells were stimulated with ghrelin for the indicated time period at 37degreesC. The media was then aspirated and the cells were lysed in ice-cold RIPA buffer [Tris-HCl (pH 7.2), 50 mM; NaCl, 150 mM; EDTA, 1 mM; NP-40, 1% (v/v); Na-deoxycholate, 0.25% (w/v); protease inhibitor cocktail (Sigma; St. Louis, Mo, USA); phosphatase inhibitor cocktail (Sigma; St. Louis, Mo, USA)]. The solubilized lysates were transferred into centrifuge tubes and left at 4degreesC for 15 min, then pre-cleared by centrifuging at 13,000xg for 15 min. Protein concentration was evaluated with the QuantiProtrade mark BCA assay kit (Sigma; St. Louis, Mo, USA). Subsamples (same amount of protein) of each sample were separated on 10% SDS-polyacrylamide gels and transferred to nitrocellulose membranes. The blots were incubated with 5% non-fat dry milk in TBST [Tris-HCl (pH 8.0), 20 mM; NaCl, 150 mM; Tween-20, 0.1% (v/v); used for all incubation and washing steps] for 1 h. Next, blots were incubated for 1 h with the corresponding antibodies according to the manufacturer's instructions. The blots were subsequently incubated with the corresponding peroxidase-conjugated IgG antibody. After washing, signals were visualized using an enhanced chemiluminescence detection system (GE-Amersham; Buckinghamshire, UK).
###end p 15
###begin title 16
Immunoprecipitation
###end title 16
###begin p 17
Serum-starved cells were stimulated with ghrelin for the indicated time period at 37degreesC and lysed in ice-cold non-denaturing NP-40 solubilization buffer [immunoprecipitation lysis buffer (ILB), Tris-HCl (pH 7.5), 20 mM; NaCl, 150 mM; EDTA, 1 mM; NP-40, 1% (v/v); protease inhibitor cocktail (Sigma, St. Louis, Mo, USA); phosphatase inhibitor cocktail (Sigma; St. Louis, Mo, USA)]. 500 microg of total protein was pre-washed with 20 microL of 50% protein A/G-agarose (Santa Cruz; Santa Cruz, CA, USA) for 30 min at 4degreesC, and then incubated with 1 microg of the corresponding antibody (overnight at 4degreesC) followed by addition of 40 microL of 50% protein A/G (2 h at 4degreesC). After washing two times with ILB, the pelleted beads were resuspended in Laemmli sample buffer. Proteins were analyzed by 10% SDS-polyacrylamide gels, followed by Western blotting.
###end p 17
###begin title 18
Small Interfering RNA (siRNA) Silencing of Gene Expression
###end title 18
###begin p 19
###xml 168 195 165 192 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAAGCCUUCUGCGCGGAGAAU-3&#8242;</named-content>
###xml 215 242 209 236 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAGGACCGCAAAGUGUUUGUG-3&#8242;</named-content>
###xml 244 271 238 265 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAAGCCUUCUGCGCGGAGAAU-3&#8242;</named-content>
###xml 273 300 267 294 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAGGACCGCAAAGUGUUUGUG-3&#8242;</named-content>
###xml 311 336 305 330 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CACUUCGAUUAGUCAGAAA-3&#8242;</named-content>
###xml 338 363 332 357 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGCUUACUUUGCCUAACAA-3&#8242;</named-content>
###xml 365 390 359 384 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCAACUGAGUGCAAUAUGU-3&#8242;</named-content>
###xml 400 424 394 418 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CUCGGCUCAUUGAAGACA-3&#8242;</named-content>
###xml 426 451 420 445 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-UGACUGAGCUCACCACAAA-3&#8242;</named-content>
###xml 453 478 447 472 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCUCAUCAUAGCAAUAACA-3&#8242;</named-content>
###xml 480 505 474 499 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GUAGAUUUCAGAUGACUAU-3&#8242;</named-content>
Chemically synthesized double-stranded siRNA duplexes (with 3' dTdT overhangs) were purchased from Santa Cruz Biothecnology for the following targets: beta-arrestin 1 (5'-AAAGCCUUCUGCGCGGAGAAU-3'), beta-arrestin 2 (5'-AAGGACCGCAAAGUGUUUGUG-3', 5'-AAAGCCUUCUGCGCGGAGAAU-3', 5'-AAGGACCGCAAAGUGUUUGUG-3'), Rictor (5'-CACUUCGAUUAGUCAGAAA-3', 5'-CGCUUACUUUGCCUAACAA-3', 5'-CCAACUGAGUGCAAUAUGU-3'), c-Src (5'-CUCGGCUCAUUGAAGACA-3', 5'-UGACUGAGCUCACCACAAA-3', 5'-CCUCAUCAUAGCAAUAACA-3', 5'-GUAGAUUUCAGAUGACUAU-3'). A non-silencing RNA duplex was used as a control for all siRNA experiments. Cells were transfected with Lipofectamine 2000 (Invitrogen; Carlsbad, CA, USA), according to manufacturers' instructions. Silencing was quantified by immunoblotting. Only experiments with verified silencing were used.
###end p 19
###begin title 20
Data analysis
###end title 20
###begin p 21
###xml 134 135 132 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The results were expressed as the mean+/-S.E. Differences between means were evaluated by one-way analysis of variance (ANOVA). (*,#, P<0.05).
###end p 21
###begin title 22
Results
###end title 22
###begin title 23
Akt temporal pattern activation by ghrelin
###end title 23
###begin p 24
###xml 0 9 0 9 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004686-g001">Figure 1A</xref>
###xml 287 290 287 290 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i/o</sub>
###xml 377 380 377 380 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i/o</sub>
###xml 440 449 440 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004686-g001">Figure 1B</xref>
###xml 829 836 812 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004686-g001">Fig. 1B</xref>
###xml 974 981 953 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004686-g001">Fig. 1B</xref>
Figure 1A shows that Akt phosphorylation in both the activation loop within the kinase domain [A-loop (T308)] and the hydrophobic motif in the C-terminal region [HM (S473)] reached maximal levels within 20 min of ghrelin stimulation (100 nM), keeping the maximum by 60 min. The role of Gi/o protein was evaluated by means of pretreatment with pertussis toxin, which uncouples Gi/o protein from receptors (PTX; 100 ng/mL, 12 h). As shown in Figure 1B, PTX reduced the ghrelin-induced phosphorylation of the Akt A-loop (T308). Surprisingly, PTX pretreatment showed an increase of Akt HM (S473) phosphorylation after ghrelin stimulation. Transfection with Gbetagamma sequesters, beta-ARK-CT, decreased the effect of ghrelin on Akt phosphorylation at both residues, indicating the involvement of the betagamma-subunit of G proteins (Fig. 1B). Pretreatment with the PI3K inhibitor wortmannin (1 microM, 30 min) decreased the ghrelin-induced Akt phosphorylation at both residues (Fig. 1B).
###end p 24
###begin title 25
###xml 9 12 9 12 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i/o</sub>
Role of Gi/o proteins, Gbetagamma dimers and PI3K in Akt phosphorylation in response to ghrelin.
###end title 25
###begin p 26
A, Time-course of the effect of ghrelin on Akt HM (S473) and A-loop (T308) phosphorylation. B, Ghrelin-induced Akt phosphorylation in the absence or presence of PTX (100 ng/mL, 12 h), PI3K inhibitor wortmannin (1 microM, 30 min) and betagamma sequester beta-ARK-CT. In A and B, serum-starved HEK-GHSR1a cells were treated with ghrelin (100 nM) at 37degreesC for the indicated times. Cells were lysed and analyzed by SDS-PAGE using specific antibodies. Akt phosphorylation was quantified by densitometry and expressed as a percentage of the maximal phosphorylation obtained for each residue (mean+/-S.E. of three independent experiments). Blots are representative of three independent experiments.
###end p 26
###begin title 27
c-Src tyrosine kinase regulates Akt activity
###end title 27
###begin p 28
###xml 328 337 320 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004686-g002">Figure 2A</xref>
###xml 408 415 398 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004686-g002">Fig. 2A</xref>
###xml 892 899 878 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004686-g002">Fig. 2B</xref>
###xml 1302 1309 1286 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004686-g002">Fig. 2C</xref>
Akt phosphorylation was strongly inhibited at both residues by the selective Src inhibitor PP2 (5 microM, 30 min) for all time tested. This inhibition was specific, since pretreatment with PP3 (5 microM, 30 min), a negative control for PP2, had no effect on the ghrelin-induced Akt phosphorylation (data not shown). As shown in Figure 2A, siRNA experiments targeting c-Src reduced its expression by 57+/-2% (Fig. 2A). In the presence of a non-targeting control siRNA, ghrelin-activated Akt phosphorylation was identical to that observed without any transfection. c-Src siRNA decreased ghrelin-activated Akt phosphorylation with respect to siRNA control for all time tested [54+/-3% at HM(S473); and, 45+/-6% at A-loop(T308)]. Immunoprecipitation assays of Akt showed an increase of Y phosphorylation of this kinase in ghrelin-treated cells (100 nM, 5 min) in comparison with untreated cells (Fig. 2B). Furthermore, the activated form of c-Src, pSrc (Y416), co-immunoprecipitated with Akt, which demonstrates a direct interaction between both kinases. Immunoprecipitation assays of Akt in the presence of c-Src siRNA (66+/-2% reduction in c-Src expression) clearly decreased Y phosphorylation of this kinase in ghrelin-treated cells (100 nM, 5 min) in comparison with non-targeting control siRNA cells (Fig. 2C). c-Src siRNA decreased ghrelin-activated Akt phosphorylation and coimmunoprecipitation of pSrc (Y416) with respect to siRNA control.
###end p 28
###begin title 29
c-Src is required for phosphorylation of Akt in response to ghrelin.
###end title 29
###begin p 30
A, Effect of siRNA depletion of c-Src on ghrelin-induced Akt phosphorylation. HEK-GHSR1a cells transfected with c-Src siRNA were serum-starved for 12 h and then stimulated with ghrelin (100 nM) at 37degreesC. After stimulation, equal amounts of protein in each sample were used to assess the expression of c-Src (left panel) and Akt phosphorylation (right panel) by western blotting. Expression of c-Src was quantified by densitometry and expressed as percentages of the level of c-Src in control siRNA-transfected cells (mean+/-S.E.). Akt phosphorylation was quantified by densitometry and expressed as a percentage of the maximal phosphorylation at HM (S473) and A-loop (T308) after ghrelin addition to control siRNA-transfected cells (mean+/-S.E.). B, Effect of ghrelin on Y phosphorylation of Akt and interaction between Akt and c-Src. Cells were incubated with ghrelin (100 nM, 5 min) at 37degreesC, lysed and immunoprecipitated (IP) with antibodies to Akt, and then analyzed by western blotting with pAkt HM(S473), pY, pSrc (Y416) antibodies. C, Effect of ghrelin on Y phosphorylation of Akt in the presence of c-Src siRNA. HEK-GHSR1a cells transfected with c-Src siRNA were serum-starved for 12 h and then stimulated with ghrelin (100 nM, 5 min) at 37degreesC. Equal amounts of protein in each sample were used to assess the expression of c-Src [upper panel; values shown (mean+/-S.E.) are percentages of the level of c-Src in control siRNA-transfected cells]. Cells were lysed and immunoprecipitated (IP) with antibodies to Akt, and then analyzed by western blotting with with pAkt HM(S473), pY, pSrc (Y416) antibodies. Immunoblots are representative of three independent experiments.
###end p 30
###begin title 31
3-phosphoinositide-dependent protein kinase 1 (PDK1) and mammalian rapamycin-insensitive complex 2 (mTORC2) mediate Akt phosphorylation activated by ghrelin
###end title 31
###begin p 32
###xml 0 9 0 9 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004686-g003">Figure 3A</xref>
###xml 496 503 480 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004686-g003">Fig. 3B</xref>
###xml 606 613 588 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004686-g003">Fig. 3C</xref>
###xml 726 733 706 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004686-g003">Fig. 3C</xref>
Figure 3A shows that pPDK1 (S241) reached maximal levels within 5-10 min of ghrelin stimulation (100 nM), decreasing to approximately50% of the maximum by 60 min after stimulation. This increase was parallel to the phosphorylation of Akt A-loop (T308). Pretreatment of cells with PTX (100 ng/mL, 12 h) had a significant inhibitory effect on ghrelin-induced pPDK1 (S241) (100 nM, 5 min). Inhibition of PI3K by wortmannin pretreatment (1 microM, 30 min) inhibited the ghrelin-induced pPDK1 (S241) (Fig. 3B). On the other hand, working in the presence of Rictor siRNA (50+/-2% reduction in Rictor expression; Fig. 3C), Akt HM (S473) phosphorylation was reduced by 50+/-4%, whereas A-loop (T308) phosphorylation was not affected (Fig. 3C).
###end p 32
###begin title 33
PDK1 and mTORC2 regulate Akt phosphorylation activated by ghrelin.
###end title 33
###begin p 34
A, Time-course of the effect of ghrelin (100 nM) on phosphorylation of PDK1. Cell extracts were analyzed by SDS-PAGE using specific antibody against pPDK1 (S241) and Akt. PDK1 phosphorylation was quantified by densitometry and expressed as a percentage of the maximal phosphorylation (mean+/-S.E of three independent experiments). B, PDK1 phosphorylation induced by ghrelin (100 nM, 5 min) in the absence or presence of PTX (100 ng/mL, 12 h) and the PI3K inhibitor wortmannin (1 microM, 30 min). PDK1 phosphorylation was quantified by densitometry and expressed as the percentage of the basal phosphorylation obtained in control cells (means+/-S.E.). C, Effects of siRNA depletion of Rictor on ghrelin-induced Akt phosphorylation. HEK-GHSR1a cells transfected with Rictor siRNA were stimulated with ghrelin (100 nM) at 37degreesC. After stimulation, cell extracts were prepared as described in Experimental Procedures. Equal amounts of protein in each sample were used to assess the expression of Rictor and Akt phosphorylation by Western blotting. Expression of Rictor was quantified by densitometry. Shown values are percentages of the level of Rictor in control siRNA-transfected cells. Akt phosphorylation was quantified by densitometry and expressed as a percentage of the maximal phosphorylation of Akt HM (S473) and A-loop (T308) after ghrelin stimulation to control siRNA-transfected cells (mean+/-S.E.). In A, B and C, blots are representative of three independent experiments.
###end p 34
###begin title 35
Regulation of Akt phosphorylation by beta-arrestins
###end title 35
###begin p 36
###xml 126 133 116 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004686-g004">Fig. 4A</xref>
###xml 653 660 617 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004686-g004">Fig. 4A</xref>
###xml 944 951 902 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004686-g004">Fig. 4B</xref>
siRNA experiments targeting beta-arrestin 1 or beta-arrestin 2 reduced their expression by 45+/-2% and 55+/-4%, respectively (Fig. 4A). In the presence of a non-targeting control siRNA, ghrelin-activated Akt phosphorylation was identical to that observed without any transfection (data not shown). beta-arrestin 1 and beta-arrestin 2 siRNA led to rapid Akt phosphorylation, which decreased after 10 min of ghrelin stimulation with respect to siRNA control [41+/-2% and 39+/-3% at HM(S473) for beta-arrestin 1 and beta-arrestin 2 siRNA, respectively; and, 47+/-5% and 40+/-4% at A-loop(T308), for beta-arrestin 1 and beta-arrestin 2 siRNA, respectively (Fig. 4A)]. This inhibitory effect stayed on both residues for at least 60 min. Immunoprecipitation of ghrelin-treated cells (100 nM, 10 min) with antibodies for beta-arrestin 1 or beta-arrestin 2 coprecipitated pAkt (T308, S473), while failed to coprecipitate pPDK1 (S241), Rictor and mTOR (Fig. 4B). The beta-arrestin-dependent Akt phosphorylation was dependent on Src as no immunoprecipitation of pAkt was obtained with antibodies to beta-arrestin 1 or beta-arrestin 2 in ghrelin stimulated cells (100 nM, 10 min) after pretreatment with PP2 (5 microM, 30 min). This inhibition was specific, since pretreatment with PP3 (5 microM, 30 min) had no effect on the beta-arrestin-dependent Akt phosphorylation induced by the agonist (data not shown).
###end p 36
###begin title 37
beta-arrestins are required for the modulation of Akt phosphorylation in response to ghrelin.
###end title 37
###begin p 38
A, Effect of siRNA depletion of beta-arrestin 1 or beta-arrestin 2 on ghrelin-induced Akt phosphorylation. HEK-GHSR1a cells transfected with beta-arrestin 1 or beta-arrestin 2 siRNA were serum-starved for 12 h and then stimulated with ghrelin (100 nM) at 37degreesC. After stimulation, equal amounts of protein in each sample were used to assess the expression of beta-arrestin 1 or beta-arrestin 2 (upper panel) and Akt phosphorylation (lower panel) by Western blotting. Expression of beta-arrestin 1 or beta-arrestin 2 was quantified by densitometry. Values shown are percentages of the level of beta-arrestins in control siRNA-transfected cells. Akt phosphorylation was quantified by densitometry and expressed as a percentage of the maximal phosphorylation at HM (S473) and A-loop (T308) after ghrelin addition to control siRNA-transfected cells (mean+/-S.E.). B, Effect of ghrelin on the assembly of complexes containing beta-arrestins 1 and 2 and pAkt. Cells were incubated with ghrelin (100 nM, 10 min) at 37degreesC, lysed and immunoprecipitated (IP) with antibodies to beta-arrestin 1 (left panel) or beta-arrestin 2 (right panel), and then analyzed by western blotting with pAkt[HM(S473), A-loop(T308), pPDK1 (S241)], Rictor, mTOR, and beta-arrestin (A1CT) antibodies. In A and B, western blots are representative of three independent experiments.
###end p 38
###begin title 39
Regulation of Akt phosphorylation by Src and beta-arrestins in 3T3-L1 preadipocyte cells
###end title 39
###begin p 40
###xml 12 21 12 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004686-g005">Figure 5A</xref>
###xml 246 253 242 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004686-g005">Fig. 5A</xref>
###xml 485 492 475 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004686-g005">Fig. 5B</xref>
###xml 611 618 595 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004686-g005">Fig. 5B</xref>
As shown in Figure 5A, both Akt A-loop (T308) and HM (S473) phosphorylation reached maximal levels within 20-60 min of ghrelin addition (100 nM). The Akt phosphorylation was inhibited at both residues by pretreatment with PP2 (5 microM, 30 min) (Fig. 5A). Immunoprecipitation of ghrelin-treated cells (100 nM, 10 min) with antibodies for beta -arrestin 1 or beta-arrestin 2 coprecipitated full-activated Akt showing an increase on tyrosine phosphorylation compared to untreated cells (Fig. 5B). Furthermore, the activated form of Src, pSrc (Y416), co-immunoprecipitated with beta-arrestin 1 or beta-arrestin 2 (Fig. 5B).
###end p 40
###begin title 41
Src and beta-arrestins regulate Akt phosphorylation in response to ghrelin in 3T3-L1 preadipocyte cells.
###end title 41
###begin p 42
A, Effects of the Src inhibitor PP2 and its negative control, PP3, on the ghrelin-induced Akt activation in 3T3-L1 preadipocyte cells. Serum-starved cells were pretreated with PP2 (5 microM, 30 min) or PP3 (5 microM, 30 min) before ghrelin stimulation (100 nM) for the indicated time periods. Akt phosphorylation was quantified by densitometry and expressed as a percentage of the maximal phosphorylation at HM (S473) and A-loop (T308) (mean+/-S.E of three independent experiments). B, Effect of ghrelin on the assembly of complexes containing beta-arrestins 1 and 2 and pAkt. Preadipocyte 3T3-L1 cells were incubated with ghrelin (100 nM, 10 min) at 37degreesC, lysed and immunoprecipitated (IP) with antibodies to beta-arrestins 1 and 2, and then analyzed by western blotting with pAkt HM (S473), pAkt A-loop (T308), pY, pSrc (Y416) antibodies. For A and B, western blots are representative of three independent experiments.
###end p 42
###begin title 43
Discussion
###end title 43
###begin p 44
###xml 157 160 157 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i/o</sub>
The present study offers three major findings related to the activation of Akt in response to ghrelin. First, Akt is phosphorylated by the interplay of two Gi/o-protein-dependent signaling pathways. One pathway is Gbetagamma-dependent and involves the activation of PI3K. The second pathway is mediated by the beta-arrestins 1 and 2, and requires the entry of the receptor into a multiprotein complex. Second, PDK1 and mTORC2 are essential for A-loop and HM phosphorylation of Akt, respectively. Third, c-Src plays an essential role in the activation of Akt mediated by ghrelin. Thus, ghrelin activates Akt pools that differ in their temporal and spatial distributions, suggesting to have different physiological targets.
###end p 44
###begin p 45
###xml 216 219 216 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Manning1">[7]</xref>
###xml 380 383 380 383 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i/o</sub>
###xml 550 551 550 551 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 553 556 553 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Camia2">[6]</xref>
###xml 705 708 691 694 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i/o</sub>
###xml 753 757 739 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Schwindinger1">[17]</xref>
###xml 773 774 759 760 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 983 987 969 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Casamayor1">[18]</xref>
###xml 989 993 975 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Storz1">[19]</xref>
###xml 1431 1435 1409 1413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Dong1">[20]</xref>
###xml 1586 1590 1564 1568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Guertin1">[21]</xref>
###xml 2170 2174 2148 2152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Biondi1">[22]</xref>
###xml 2175 2179 2153 2157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Shiota1">[25]</xref>
###xml 2329 2332 2303 2306 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i/o</sub>
###xml 2380 2383 2350 2353 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i/o</sub>
###xml 2599 2603 2569 2573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Gao1">[26]</xref>
###xml 2605 2609 2575 2579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Brognard1">[27]</xref>
###xml 2763 2767 2733 2737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Guertin1">[21]</xref>
###xml 3008 3012 2978 2982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Schroder1">[28]</xref>
###xml 3264 3268 3234 3238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Schroder1">[28]</xref>
###xml 3270 3274 3240 3244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Lee1">[29]</xref>
The protein kinase Akt has emerged as a pivotal signaling node that regulates the control of cell proliferation, nutrient uptake and metabolism in a cell-type-specific manner through a variety of down-stream targets [7]. From the results presented so far, ghrelin activates Akt by two distinct phosphorylation events, both of which depend on PI3K. GHS-R1a activates PI3K through Gi/o protein to regulate several downstream signaling pathways through the generation of the lipid second messenger phosphatidylinositol-3,4,5-triphosphate [PtdIns(3,4,5)P3] [6]. Since expression of Gbetagamma sequestrant inhibited both Akt HM (S473) and A-loop (T308) phosphorylation, we suggest that Gbetagamma dimers from Gi/o are the upstream signal for PI3K activation [17]. PtdIns(3,4,5)P3 allows membrane translocation of proteins containing PH domain such as PDK1 and Akt. Then, PDK1 is autophosphorylated at Ser241 leading to its own activation and consequently phosphorylates Akt A-loop (T308) [18], [19]. Finally, the full activation of Akt involves the phosphorylation of HM (S473). Several kinases, designated as PDK2 kinases, have been proposed to phosphorylate the Akt HM (S473) kinase; from those at least 10 of them may function as PDK2, including integrin-linked kinase (ILK), protein kinase Calpha (PKCalpha), double-stranded DNA-dependent protein kinase (DNA-PK), ataxia telangengiectasia mutated (ATM) gene product, and the mTORC2 [20]. From all the proposed candidates, evidence supports mTORC2 as the most compelling. mTORC2 contains Rictor, mLST8, mSin1 variants and the mTOR kinase [21]. Our study shows that ablating mTORC2 function by siRNA targeting Rictor impaired ghrelin-stimulated HM (S473) phosphorylation of Akt, but not at the A-loop (T308). This result identifies the hypothetical ghrelin-activated PDK2 as mTORC2. The fact that the Akt A-loop (T308) phosphorylation is unaffected by loss of HM (S473) phosphorylation in mTORC2-deficient cells, supports that the phosphorylation of HM (S473) is not critical for that of A-loop (T308). Thus, the PDK1-mediated Akt A-loop (T308) phosphorylation is not dependent on prior HM (S473) phosphorylation by mTORC2 [22]-[25]. Interestingly, PTX treatment selectively enhanced earliest time points of Akt HM (S473) phosphorylation, consistent with a regulatory role of Galphai/o protein. This opens the possibility that Galphai/o regulates the activation of the recently discovered PH domain leucine-rich repeat phosphatase (PHLPP1 and PHLPP2), phosphatases that selectively dephosphorylate the HM of Akt, resulting in decreased kinase activity [26], [27]. These results support the model by which both Akt and PDK1 interact by colocalization at the plasma membrane, which is further phosphorylated by mTORC2 [21]. Despite being a key element in the Akt activation, the way mTORC2 is activated remains unknown. Based on the PH-like domain of mSIN1, mTORC2 and Akt might interact as consequence of colocalization at plasma membrane when PI3K is activated [28]. This does not exclude the possibility that other upstream signals regulate phosphorylation/activation of the mTORC2 in response to different growth factors. Indeed mSIN1 contains a Ras-binding domain raising the possibility that Ras regulates mTORC2 [28], [29].
###end p 45
###begin p 46
###xml 252 255 249 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Camia2">[6]</xref>
###xml 563 567 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Chen1">[30]</xref>
###xml 569 573 566 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Conus1">[31]</xref>
###xml 923 927 920 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Jiang1">[32]</xref>
###xml 1092 1093 1089 1090 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1384 1388 1381 1385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Jiang1">[32]</xref>
c-Src kinase is involved in the MAPK activation in response to ghrelin. Ghrelin induces a first "wave" of c-Src activation via G protein-dependent signaling that it is followed by a second wave of c-Src activation via beta-arrestins-mediated signaling [6]. In the present work, c-Src acts upstream of Akt, as c-Src depletion using siRNAs reduced the ghrelin-induced Akt phosphorylation at both A-loop (T308) and HM (S473). It was reported that, in addition to phosphorylation of A-loop (T308) and HM (S473), Y phosphorylation is also essential for Akt activation [30], [31]. Our data indicate that ghrelin activates Y phosphorylation of Akt, although the detailed mechanism of this regulation remains to be elucidated. Additionally, coimmunoprecipitation assays showed that c-Src interacts with Akt in response to ghrelin. Because c-Src contains an SH3 domain, it was proposed that Src interacts with the PXXP motif of Akt [32]. Our data are consistent with this previously proposed model in which Akt translocates to the plasma membrane through the binding of its PH domain to PtdIns(3,4,5)P3 generated by PI3K. This allows the interaction of membrane bound Src and Akt through its PXXP motif in the C-terminal regulatory region and the SH3 domain of Src. Then Src phosphorylates Akt at Y residue(s), which triggers Akt A-loop (T308) and HM (S473) phosphorylation by PDK1 and mTORC2 [32]. These data support the idea that Src operates as a "switch" in concert with PI3K for activation of Akt in response to ghrelin.
###end p 46
###begin p 47
###xml 635 638 620 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Camia2">[6]</xref>
###xml 1501 1504 1468 1471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Camia2">[6]</xref>
###xml 1637 1638 1601 1602 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1761 1765 1722 1726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Beaulieu1">[33]</xref>
###xml 1767 1771 1728 1732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Beaulieu2">[34]</xref>
###xml 1801 1802 1762 1763 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1802 1806 1763 1767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Buchanan1">[35]</xref>
###xml 1814 1818 1775 1779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Povsic1">[36]</xref>
###xml 1835 1839 1792 1796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Goel1">[37]</xref>
###xml 1871 1875 1825 1829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Noma1">[38]</xref>
###xml 1877 1881 1831 1835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Morisco1">[39]</xref>
The existence of a pathway involving receptor endocytosis is supported by the fact that beta-arrestin depletion using siRNAs reduced the magnitude of Akt activation by ghrelin. Our coimmunoprecipitation assays indicate that the beta-arrestins function as adaptors recruiting Akt to the ghrelin-occupied receptor through the formation of beta-arrestin complexes. The mechanism of activation of Akt-associated to beta-arrestins is not completely delineated. From the data presented so far, c-Src is essential for Akt activation even when is associated to beta-arrestins. Given that c-Src is recruited to GHS-R1a upon ghrelin stimulation [6], it would be possible that Akt interacts with Src associated to GHSR1a-beta-arrestin complex as consequence of colocalization at plasma membrane when PI3K is activated in response to ghrelin. This Akt-c-Src association is presumed to initiate Akt phosphorylation by allowing Y phosphorylation. Furthermore, beta-arrestin-scaffolded complex presumably places the different components of the Akt cascade in close proximity to each other and thus ensuring substrate specificity. This is supported by the fact that neither PDK1 nor mTORC2 coimmunoprecipitated with beta-arrestins. Interestingly, both beta-arrestin 1 and beta-arrestin 2 are required to promote the activation of Akt. The requirement of both proteins might be indicative of a need to form heterodimers to activate the beta-arrestin-dependent signaling pathway as it was described for MAPK activation [6]. However, this cannot be generalized, since in other systems beta-arrestins show opposite effects. For example, in the case of the D2-class receptors, beta-arrestin 2 facilitates the dephosphorylation of Akt by phosphatase 2 (PP2A) in response to dopamine [33], [34]. In addition, prostaglandin E2[35], IGF-1 [36], alpha-thrombin [37] and beta1-adrenergic receptors [38], [39] activate Akt pathway through beta-arrestin 1 dependent mechanisms. It seems that each receptor determine the beta-arrestin-associated functions on basis of the receptor-associated isoforms.
###end p 47
###begin p 48
###xml 111 114 111 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Xu1">[8]</xref>
###xml 115 119 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Duxbury1">[15]</xref>
###xml 245 246 245 246 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004686-Kim1">[14]</xref>
###xml 880 881 877 878 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 928 931 925 928 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i/o</sub>
###xml 1424 1430 1415 1421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004686-g006">Fig. 6</xref>
###xml 1521 1524 1512 1515 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i/o</sub>
It has been shown that ghrelin regulates the Akt activity through the GHS-R1a in a variety of cellular systems [8]-[15]. Particularly, the mitogenic effect of ghrelin in 3T3-L1 preadipocytes is mediated by the PI3K/Akt and MAPK pathways, via a Gi-protein [14]. Accordingly to our results in HEK-GHSR1a cells, co-immunoprecipitation assays performed in 3T3-L1 cells indicate that beta-arrestins recruit Akt, leading to its activation. c-Src acts upstream of Akt in these cells, as PP2 abolished the ghrelin-induced Akt phosphorylation at both residues. Furthermore, co-immunoprecipitation assays showed that c-Src interacts with Akt in response to ghrelin allowing the phosphorylation of Akt at Y residue(s). Therefore, our data are consistent with a model in which Akt translocates to the plasma membrane through the binding of its PH domain to the second messenger PtdIns(3,4,5)P3 generated by PI3K which is activated through Gi/o-protein dependent signaling pathway. Akt is phosphorylated at Y by the membrane bound Src via the interaction between its C-terminal proline-rich motif and the SH3 domain of Src. This Y phosphorylation is followed by phosphorylation of Akt A-loop (T308) and HM (S473) by PDK1 and mTORC2 respectively. Once the receptor is activated, a second signaling pathway is mediated by beta-arrestins 1 and 2 involving the recruitment of GHS-R1a, c-Src and Akt into an beta-arrestin-scaffolded complex (Fig. 6). Thus c-Src functions as a switch that initiates the Akt pathway associated to both the Gi/o-protein dependent pathway and beta-arrestin-scaffolded complex.
###end p 48
###begin title 49
Model of upstream activation of Akt by ghrelin.
###end title 49
###begin p 50
###xml 93 94 93 94 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 130 133 130 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i/o</sub>
Binding of ghrelin to GHS-R1a activates the generation of the second messenger PtdIns(3,4,5)P3 (PIP3) by PI3K activation through Gi/o-protein dependent signaling pathway. Akt translocates to the plasma membrane by binding to PIP3 where it is phosphorylated at Y by the membrane bound c-Src. This phosphorylation (Y) is followed by phosphorylation of Akt A-loop (T308) and HM (S473) by PDK1 and mTORC2 respectively. Once the receptor is activated, a second signaling pathway is mediated by beta-arrestins 1 and 2, involving the recruitment of GHS-R1a, c-Src and Akt into an beta-arrestin-scaffolded complex.
###end p 50
###begin p 51
We thank Prof. R.J. Lefkowitz for antibody against beta-arrestins (Howard Hughes Medical Institute and the Departments of Medicine and Biochemistry, Duke University Medical Center).
###end p 51
###begin title 52
References
###end title 52
###begin article-title 53
Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin.
###end article-title 53
###begin article-title 54
Desensitization and endocytosis mechanisms of ghrelin-activated growth hormone secretagogue receptor 1a.
###end article-title 54
###begin article-title 55
Importance of constitutive activity and arrestin-independent mechanisms for intracellular trafficking of the ghrelin receptor.
###end article-title 55
###begin article-title 56
The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals.
###end article-title 56
###begin article-title 57
Beta-arrestins and cell signaling.
###end article-title 57
###begin article-title 58
Stimulation by ghrelin of p42/p44 mitogen-activated protein kinase through the GHS-R1a receptor: role of G-proteins and beta-arrestins.
###end article-title 58
###begin article-title 59
AKT/PKB signaling: navigating downstream.
###end article-title 59
###begin article-title 60
Molecular Mechanisms of Ghrelin-Mediated Endothelial Nitric Oxide Synthase Activation.
###end article-title 60
###begin article-title 61
Ghrelin has novel vascular actions that mimic PI 3-kinase-dependent actions of insulin to stimulate production of NO from endothelial cells.
###end article-title 61
###begin article-title 62
###xml 53 58 <span type="species:ncbi:9606">human</span>
Ghrelin inhibits angiotensin II-induced migration of human aortic endothelial cells.
###end article-title 62
###begin article-title 63
###xml 21 26 <span type="species:ncbi:9606">human</span>
Effect of ghrelin on human endothelial cells apoptosis induced by high glucose.
###end article-title 63
###begin article-title 64
###xml 72 76 <span type="species:ncbi:10116">rats</span>
Ghrelin enhances in vivo skeletal muscle but not liver AKT signaling in rats.
###end article-title 64
###begin article-title 65
Ghrelin enhances the proliferating effect of thyroid stimulating hormone in FRTL-5 thyroid cells.
###end article-title 65
###begin article-title 66
The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes.
###end article-title 66
###begin article-title 67
Ghrelin promotes pancreatic adenocarcinoma cellular proliferation and invasiveness.
###end article-title 67
###begin article-title 68
Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zac1 expression.
###end article-title 68
###begin article-title 69
Heterotrimeric G-protein betagamma-dimers in growth and differentiation.
###end article-title 69
###begin article-title 70
Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in vivo.
###end article-title 70
###begin article-title 71
3'-phosphoinositide-dependent kinase-1 (PDK-1) in PI 3-kinase signaling.
###end article-title 71
###begin article-title 72
PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle.
###end article-title 72
###begin article-title 73
Defining the role of mTOR in cancer.
###end article-title 73
###begin article-title 74
The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB.
###end article-title 74
###begin article-title 75
###xml 12 16 <span type="species:ncbi:10090">mice</span>
Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1.
###end article-title 75
###begin article-title 76
SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity.
###end article-title 76
###begin article-title 77
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability.
###end article-title 77
###begin article-title 78
PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth.
###end article-title 78
###begin article-title 79
PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms.
###end article-title 79
###begin article-title 80
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Sin1 contains Ras-binding and pleckstrin homology domains and suppresses Ras signalling.
###end article-title 80
###begin article-title 81
TOR complex 2 integrates cell movement during chemotaxis and signal relay in Dictyostelium.
###end article-title 81
###begin article-title 82
Regulation of Akt/PKB activation by tyrosine phosphorylation.
###end article-title 82
###begin article-title 83
Direct identification of tyrosine 474 as a regulatory phosphorylation site for the Akt protein kinase.
###end article-title 83
###begin article-title 84
Interaction between Src and a C-terminal proline-rich motif of Akt is required for Akt activation.
###end article-title 84
###begin article-title 85
A beta-arrestin 2 signaling complex mediates lithium action on behavior.
###end article-title 85
###begin article-title 86
An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior.
###end article-title 86
###begin article-title 87
Role of beta-arrestin 1 in the metastatic progression of colorectal cancer.
###end article-title 87
###begin article-title 88
Beta-arrestin1 mediates insulin-like growth factor 1 (IGF-1) activation of phosphatidylinositol 3-kinase (PI3K) and anti-apoptosis.
###end article-title 88
###begin article-title 89
alpha-Thrombin induces rapid and sustained Akt phosphorylation by beta-arrestin1-dependent and -independent mechanisms, and only the sustained Akt phosphorylation is essential for G1 phase progression.
###end article-title 89
###begin article-title 90
Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection.
###end article-title 90
###begin article-title 91
###xml 96 99 <span type="species:ncbi:10116">rat</span>
Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes.
###end article-title 91
###begin p 92
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 92
###begin p 93
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from Instituto de Salud Carlos III (Ministerio de Ciencia e Innovacion: PI060239, PI060705, PI070908), and Xunta de Galicia (PGIDIT05BTF20802PR, PGIDIT06PXIB918322PR, PGIDIT06PXIB918360PR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work of M Lodeiro is funded by Instituto de Salud Carlos III (Ministerio de Ciencia e Innovacion). The work of M Theodoropoulou was supported by a research fellowship at the University of Santiago de Compostela for the Pfizer Young Investigator Fellowship. The work of JP Camina is funded by the Instituto de Salud Carlos III (Ministerio de Ciencia e Innovacion) and the Xunta de Galicia (SERGAS) through a research-staff stabilization contract.
###end p 93

